ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality Therapy.

Elizabeth S Duke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.